Sprint Bioscience AB · LSX:A14NY2

Sprint Bioscience AB financial statements

Sprint Bioscience AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue167.2M65.6M50.5M83.0K35.1M16.9M33.5M17.9M24.0M35.0M
Cost of revenue69.8M28.3M8.70M61.0M10.4M10.5M8.17M745.0K2.99M418.5K
Gross profit97.3M37.3M41.8M-60.9M24.7M6.43M25.4M17.2M21.0M34.6M
Research and development2.88M
Selling, general and administrative34.1M33.6M26.4M31.4M22.2M21.1M18.3M17.2M13.2M11.1M
Operating income97.3M-19.7M-845.0K-60.9M-25.5M-37.7M-20.4M-22.1M-10.7M4.57M
Depreciation and amortization1.07M958.0K447.0K618.0K590.0K697.0K731.0K704.0K564.0K451.2K
EBITDA98.4M-18.7M-398.0K-60.3M-24.9M-37.0M-19.7M-21.4M-10.1M5.02M
Interest expense6.21M40.0K387.0K42.0K269.0K3.44M1.21M137.0K42.0K84.7K
Income before tax91.7M-18.3M-438.0K-60.2M-25.1M-42.8M-21.5M-22.2M-10.7M4.54M
Income tax279.1K741.0K269.0K3.44M1.21M7.00K-292.0K221.7K
Net income91.7M-18.3M-438.0K-60.2M-25.4M-46.2M-22.7M-22.2M-10.7M4.54M
Earnings per share, basic0.99-0.26-0.01-1.43-0.73-2.23-1.51-1.88-1.090.50

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents126.7M25.1M49.9M29.5M70.6M27.1M8.38M14.7M1.48M23.6M
Receivables6.17M12.2M7.94M3.38M2.99M2.79M5.28M219.0K2.69M1.87M
Inventory-7.14M-1.00K11.91M1-219.0K-692.0K-2.67M
Current assets132.9M37.2M57.9M34.9M75.9M32.3M17.4M18.3M4.88M26.9M
Property, plant and equipment3.74M4.72M4.38M2.37M2.99M872.0K1.57M2.21M1.51M1.87M
Total assets136.7M42.1M62.4M37.4M79.1M33.4M19.2M59.3M35.5M49.5M
Accounts payable4.40M5.44M5.71M3.73M2.92M3.40M2.59M4.71M3.39M3.62M
Current liabilities17.5M32.8M34.6M9.23M8.68M24.3M8.23M22.0M7.40M21.0M
Long-term debt00
Total debt10.0M12.0M769.2K
Total liabilities17.5M32.8M34.6M9.23M8.68M24.3M8.23M22.0M7.40M21.0M
Shareholders' equity119.2M9.27M27.8M28.2M70.5M9.14M11.0M37.2M28.1M28.5M
Shares outstanding92.6M69.8M69.8M42.1M34.7M20.7M15.0M11.8M9.81M9.12M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations83.5M-23.4M22.9M-59.1M-40.1M-32.2M-28.0M-19.1M-23.1M7.93M
Capital spending-94.0K-1.30M-2.45M-2.00K-2.71M-2.71M-93.0K-11.1M-8.56M-9.91M
Free cash flow83.4M-24.7M20.4M-59.1M-42.8M-32.2M-28.1M-30.2M-31.6M-1.97M
Cash from investing-54.0K-1.30M-2.45M0-2.71M-2.71M-389.0K-11.1M-8.56M-9.91M
Cash from financing18.2M-225.0K24.0K17.9M86.4M50.9M22.1M43.4M9.49M17.8M
Share buybacks18.2M-225.0K24.0K17.9M88.8M48.9M36.2M37.9M10.3M18.6M
Change in cash101.6M-24.9M20.4M-41.2M43.6M18.7M-6.31M13.2M-22.1M16.0M